Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
|
|
Intec Pharma Ltd. (NTEC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/18/2020 |
4
| Sassi Nir (CFO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 100,000 options to buy
@ $0.3215, valued at
$32.2k
|
|
| 09/18/2020 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 100,000 options to buy
@ $0.3215, valued at
$32.2k
|
|
| 09/18/2020 |
4
| Navon Nadav (COO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 100,000 options to buy
@ $0.3215, valued at
$32.2k
|
|
| 07/17/2020 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 40,000 options to buy
@ $0.3075, valued at
$12.3k
|
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Dexcel Pharma Technologies Ltd. (10% Owner) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Sold 725,951 shares
@ $0.309, valued at
$224.3k
Sold 80,000 shares
@ $0.318, valued at
$25.4k
Sold 110,000 shares
@ $0.29, valued at
$31.9k
|
|
| 11/21/2019 |
4
| Silberman Issac (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Sold 1,000 shares
@ $0.504, valued at
$504 |
|
| 09/16/2019 |
4
| Sassi Nir (CFO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 200,000 options to buy
@ $0.9, valued at
$180k
|
|
| 09/16/2019 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 200,000 options to buy
@ $0.9, valued at
$180k
|
|
| 08/29/2019 |
4
| Meckler Jeffrey A (CEO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Bought 20,000 shares
@ $0.681, valued at
$13.6k
|
|
| 08/29/2019 |
4
| MADDALUNA ANTHONY J (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Bought 25,000 shares
@ $0.47, valued at
$11.8k
|
|
| 08/27/2019 |
4
| KOZARICH JOHN W (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Bought 100,000 shares
@ $0.459, valued at
$45.9k
|
|
| 08/27/2019 |
4
| Meckler Jeffrey A (CEO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Bought 100,000 shares
@ $0.457, valued at
$45.7k
|
|
| 07/02/2019 |
4
| Silberman Issac (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $4.858, valued at
$97.2k
|
|
| 07/02/2019 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $4.858, valued at
$97.2k
|
|
| 07/02/2019 |
4
| MADDALUNA ANTHONY J (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $4.858, valued at
$97.2k
|
|
| 07/02/2019 |
4
| Karah Hila (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $4.858, valued at
$97.2k
|
|
| 07/02/2019 |
4
| Hayes William B (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $4.858, valued at
$97.2k
|
|
| 07/02/2019 |
4
| Bianco Gil (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $4.858, valued at
$97.2k
|
|
| 04/05/2019 |
4
| Meckler Jeffrey A (CEO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 125,000 options to buy
@ $7.64, valued at
$955k
|
|
| 01/23/2019 |
4
| GENDREAU R MICHAEL (Chief Medical Officer) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 110,000 options to buy
@ $7.628, valued at
$839.1k
|
|
| 01/23/2019 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 90,000 options to buy
@ $7.628, valued at
$686.5k
|
|
| 01/23/2019 |
4
| Navon Nadav (COO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 90,000 options to buy
@ $7.628, valued at
$686.5k
|
|
| 01/23/2019 |
4
| Sassi Nir (CFO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 90,000 options to buy
@ $7.628, valued at
$686.5k
|
|
|
|